John Fraher is an experienced leader in the pharmaceutical industry with a robust background in various leadership roles. Currently serving as a Board Member for DOC GENERICI and Ellodi Pharmaceuticals, Fraher previously held prominent positions including CEO of Adare Pharmaceuticals and Eurand, where significant accomplishments include leading Eurand through a successful acquisition. Additional leadership experience includes the role of President at Aptalis Pharma and various positions at Fort Dodge Animal Health and Sterling Drug. Fraher holds a B.Sc. (Hons) in Biochemistry from University College Dublin.